Engineering nanoparticle probes for detecting disease and monitoring therapy with computed tomography

Ryan Roeder


University of Notre Dame; Founder, Spinesmith LLC

Dr. Roeder's research interests broadly span biomaterials, including nanoparticles for targeted contrast agents and drug delivery, and scaffolds for repairing and regenerating tissues, as well biomechanics, including the mechanobiology and micromechanics of musculoskeletal tissues.  Dr. Roeder's research has been supported by the National Science Foundation (NSF), the National Institutes of Health (NIH), the U.S. Army Medical Research and Materiel Command (USAMRMC), the Congressionally-Directed Medical Research Programs (CDMRP), the Defense Advanced Research Projects Agency (DARPA), as well as a number of private foundations and corporations.  Dr. Roeder’s research group is multidisciplinary, including students with backgrounds in biomedical engineering, materials engineering, mechanical engineering, chemical engineering, and chemistry.  Ph.D. graduates have been placed in postdoctoral positions, research hospitals, biomedical industry positions, and faculty positions.  Dr. Roeder's research has led to the formation of HAPPE Spine LLC which is commercializing porous and bioactive interbody spinal fusion cages composed hydroxyapatite whisker reinforced polyetheretherketone.